Phosphorylation by IKKβ Promotes the Degradation of HMGCL via NEDD4 in Lung Cancer
Open Access
- 1 January 2023
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 19 (4) , 1110-1122
Abstract
Inflammation and metabolic reprogramming are hallmarks of cancer. How inflammation regulates cancer metabolism remains poorly understood. In this study, we found that 3-hydroxy-3-methylglutaryl-CoA lyase (HMGCL), the enzyme that catalyzes the catabolism of leucine and promotes the synthesis of ketone bodies, was downregulated in lung cancer. Downregulation of HMGCL was associated with a larger tumor size and a shorter overall survival time. In a functional study, overexpression of HMGCL increased the content of β-hydroxybutyrate (β-HB) and inhibited the tumorigenicity of lung cancer cells, and deletion of HMGCL promoted de novo tumorigenesis in KP (KrasG12D;P53f/f) mice. Mechanistically, tumor necrosis factor α (TNFα) treatment decreased the HMGCL protein level, and IKKβ interacted with HMGCL and phosphorylated it at Ser258, which destabilized HMGCL. Moreover, NEDD4 was identified as the E3 ligase for HMGCL and promoted its degradation. In addition, mutation of Ser258 to alanine inhibited the ubiquitination of HMGCL by NEDD4 and thus inhibited the anchorage-independent growth of lung cancer cells more efficiently than did wild-type HMGCL. In summary, this study demonstrated a link between TNFα-mediated inflammation and cancer metabolism.Keywords
This publication has 39 references indexed in Scilit:
- The Emerging Hallmarks of Cancer MetabolismCell Metabolism, 2016
- Rapid modelling of cooperating genetic events in cancer through somatic genome editingNature, 2014
- Quantitative Proteomics Reveals That Enzymes of the Ketogenic Pathway Are Associated with Prostate Cancer ProgressionMolecular & Cellular Proteomics, 2013
- Mechanistic links between COPD and lung cancerNature Reviews Cancer, 2013
- The diverse and complex roles of NF-κB subunits in cancerNature Reviews Cancer, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Oncogenic Role of the E3 Ubiquitin Ligase NEDD4-1, a PTEN Negative Regulator, in Non-Small-Cell Lung CarcinomasThe American Journal of Pathology, 2010
- Integrating cell-signalling pathways with NF-κB and IKK functionNature Reviews Molecular Cell Biology, 2007
- The IKK NF-κB system: a treasure trove for drug developmentNature Reviews Drug Discovery, 2004
- 3-Hydroxy-3-Methylglutaryl CoA Lyase (HL): Mouse and Human HL Gene (HMGCL) Cloning and Detection of Large Gene Deletions in Two Unrelated HL-Deficient PatientsGenomics, 1996